Alex Gaither manages a drug discovery team and several drug target validation projects at Novartis. His team’s mission is to identify novel oncogenes to validate their functional role and investigate their feasibility as therapeutic targets feasibility. A core team of researchers supports the portfolio validation process, including five biology labs, a histopathology group, quantitative biology […]
CRISPR/Cas9
View current market data on lab budgets, current funding, brand preferences, workflow, satisfaction and loyalty powered by the Interactive Market Intelligence platform. Users can drill down into the data by brand, market segment and region and easily create custom presentations.
1. Gene Editing Gene editing is a type of genetic engineering. DNA is inserted, replaced, or removed from a genome using artificially engineered nucleases. A nuclease is an enzyme capable of cleaving the bonds between the subunits of nucleic acids. The nucleases create specific double-strand breaks at target locations in the genome and harness the […]
Pay Invoice
Latest Blogs
-
Winners of the 2021 Life Science Industry Awards for Innovation
December 9, 2021 12:13 pm
-
COVID-19 Testing at the Community Level – Digital PCR is a Key Tool
March 30, 2021 11:47 am
-
CRISPR: Saving the World or Playing with Dynamite?
October 27, 2020 2:01 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.